CYSTADROPS
Live / Registered — Registered — Section 71 accepted (as of 23 May 2024)
What this means for you
Registered since 31 Oct 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 31 Oct 2027: the §71 ten-year affidavit of use).
Record
- Serial number
- 79201834
- Registration number
- 5319533
- Mark type
- Word mark
- Filed
- 06 Dec 2016
- Published for opposition
- 15 Aug 2017
- Registered
- 31 Oct 2017
- Next maintenance filing
- §71 ten-year affidavit of use, due by 31 Oct 2027 (grace period to 30 Apr 2028)
- Attorney of record
- Anthony P. Venturino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and medicines known as orphans for treating rare diseases and disorders including certain eye diseases or the consequences on sight of certain rare diseases such as cystinosis [ ; sanitary and dietetic products, namely, chemical preparations for sanitary use, disinfectants for sanitary purposes, disinfectants for medical use in connection with the above diseases ]
Owner
- RECORDATI RARE DISEASES, FR
- RECORDATI RARE DISEASES, Puteaux, FR
- RECORDATI ORPHAN DRUGS, FR
- RECORDATI ORPHAN DRUGS, FR
- RECORDATI ORPHAN DRUGS, FR
Prosecution history
- 12 Mar 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 20 Jun 2025 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 17 Apr 2025 — INTERNATIONAL REGISTRATION RENEWED
- 11 Apr 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 11 Apr 2025 — INVALIDATION PROCESSED
- 04 Apr 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 28 Feb 2025 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 23 Jan 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 23 May 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 23 May 2024 — REGISTERED-SEC.71 ACCEPTED
- 21 May 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Oct 2023 — CHANGE OF OWNER RECEIVED FROM IB
- 29 Sept 2023 — TEAS SECTION 71 RECEIVED
- 31 Oct 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 12 Jun 2021 — NEW REPRESENTATIVE AT IB RECEIVED